Trade REPL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Replimune Group, Inc. (REPL) is trading at US$13.07, up 1.55% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.39B. Over the past 52 weeks, REPL has traded between US$1.50 and US$16.33. On Syfe you can trade REPL with $0 commission and add it to your watchlist.
| Previous close | US$12.87 |
|---|---|
| Market cap | US$1.39B |
| 52-week range | US$1.50 – US$16.33 |
| Volume | 2.14M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Replimune Group, Inc.
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Year: 2018
Replimune Fiscal Q1 Net Loss Narrows
Aug 14, 12:26 PM · MT Newswires
--Earnings Flash (REPL) Replimune Posts Fiscal Q1 Net Loss $0.72 a Share, vs. FactSet Est of $0.66 Loss
Aug 14, 12:09 PM · MT Newswires
Replimune Prices $150 Million Offering
Aug 10, 1:48 PM · MT Newswires
Wedbush Upgrades Replimune Group to Outperform From Neutral, Adjusts PT to $19 From $12
Aug 7, 11:15 AM · MT Newswires
Leerink Partners Upgrades Replimune Group to Outperform From Market Perform, Adjusts Price Target to $17 From $11
Aug 4, 11:44 AM · MT Newswires
Replimune Group, Inc. (REPL) stock is trading at US$13.07, +1.55% from the previous close of US$12.87.
The market cap for Replimune Group, Inc. (REPL) stock is approximately US$1.39B.
The 52-week high for Replimune Group, Inc. (REPL) stock is US$16.33.
The 52-week low for Replimune Group, Inc. (REPL) stock is US$1.50.
Replimune Group, Inc. (REPL) does not currently pay a dividend.
Stay on top of REPL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
